hereditary disease Centogene Q1 Revenues Grow More Than Fivefold Driven by COVID-19 Testing Core diagnostic testing revenues were €6.4 million, down 15 percent year over year, while pharmaceutical revenues totaled €3.6 million, down 22 percent. Molecular Health Inks Agreement for Precision Medicine Tools With Falco Biosystems The tools are part of Molecular Health's MH Guide platform, which analyzes sequencing data to identify and report on disease-related gene variants. Natera Revenues Grow 35 Percent in Q4 The company reported $112.4 million in revenues compared to $83.2 million in Q4 2019, beating the average Wall Street estimate of $106.6 million. German Medical Center to Report Polygenic Risk Scores as Part of Clinical Whole-Genome Testing Premium Under the Ge-Med project, University Hospital Tübingen will offer diagnostic whole-genome sequencing for all genetic indications and will include PRS in its reporting. Twist Bioscience, Victorian Clinical Genetic Services Develop Diagnostic Exome Assay The assay combines Twist's Human Comprehensive Exome with customized content for rare and inherited diseases from Australia-based VCGS. Feb 2, 2021 Devyser Diagnostics Raises $15.4M Through Private Placement Jan 29, 2021 Stanford Launches Clinical Whole-Genome Sequencing for Inherited Cardiovascular Testing Premium Nov 19, 2020 Putting Expanded Carrier Screening Into Practice Requires Considerations to Avoid Pitfalls Premium Oct 30, 2020 ESHG, ACMG Differ Starkly in Recommendations for Reporting Secondary Findings From Genomic Tests Premium Oct 28, 2020 Finnish Population Genomics Study Uncovers Rare, Recessive Disease Candidates Premium Jun 18, 2020 State-Funded Rapid WGS Pilot Improves Outcomes, Saves Costs in Critically Ill California Newborns Premium Jun 17, 2020 Natera Sues Progenity, Alleging Noninvasive Prenatal Test Infringes Patents Jun 15, 2020 Centogene Q1 Revenues Increase 13 Percent Jan 23, 2020 Geisinger National Experts Join Genome Medical to Help Implement Population Genomics Programs Premium Jan 22, 2020 Quest Diagnostics Acquires Blueprint Genetics Jan 8, 2020 RNA-Seq in Blood Cell Line Enables Molecular Diagnosis of Neurodevelopmental Disorders Premium Dec 5, 2019 Centogene Q3 Revenues Decrease 13 Percent Due to Non-Recurring Payments From Pharma Partners Nov 5, 2019 FindGene Noninvasive Prenatal Screening Kit Gets Approval from Chinese Regulators Oct 3, 2019 Blueprint Genetics to Open North American Lab as Biopharma Business Grows Premium Sep 24, 2019 Blueprint Genetics, Archimedlife to Launch Biochemical Rare Disease Testing in North America Aug 30, 2019 Hereditary Cancer Risk Variants Found in Significant Subset of Metastatic Breast Cancer Patients Jul 26, 2019 Invitae Reflects on Consumer-Initiated Test Pilot, Plans Improvements to Counseling Outreach Premium Apr 3, 2019 BGI Americas, AiLife Team on Clinical WGS Diagnostic Test Jan 28, 2019 Baylor NIPT for Dominant Single-Gene Disorders May Expand Existing Prenatal Screening Premium Jan 8, 2019 Illumina to Launch New NovaSeq Chip, iSeq Kit; Grow Oncology and Reproductive Health Business Load More Breaking News Pacific Biosciences, Rady Children's Collaborate on Study of WGS-Based Rare Disease Dx Codex DNA Closes $122.7M IPO Infinity BiologiX to Offer Cytox Alzheimer's Disease Genetic Risk Test in US Archaic Hominin History, Interactions Revealed With Denisova Cave Sediment Sequences Liquid Biopsy Startup Adela Launches With $60M Series A Financing Round Genomic Testing Cooperative's Hematologic Neoplasms, Solid Tumor Tests Receive NY State Approval, Medicare Coverage The Scan NFTs for Genome Sharing Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data. Wastewater Warning System Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19. Networks to Boost Surveillance Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance. Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.